Prot #ME-522-001 : A Phase 1, Open-Label, Study of Voruciclib in Subjects with Relapsed and/or Refractory B-Cell Malignancies or Acute Myeloid Leukemia After Failure of Prior Standard Therapies

Project: Research project

Project Details

StatusActive
Effective start/end date10/16/20 → 10/26/26

Funding

  • Medpace Clinical Research LLC ((OE) Prot #ME-522-001 // (OE) Prot #ME-522-001)
  • MEI Pharma, Inc. ((OE) Prot #ME-522-001 // (OE) Prot #ME-522-001)